Bruce McAvaney has poured fuel on the burning rumour that the Australian sporting icon could be making a comeback to AFL ...

Gout Gout has been compared to an Australian track legend as his meteoric rise continues. The teenage sensation has already ...

The Rise and Fall of a Border Family tells the story of an Italian immigrant and con man who ran Mexico’s biggest money ...

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in recurrence.

Efforts to combat hyperuricemia may find help from gut microbes, according to Dylan Dodd, MD, PhD, who spoke at the annual ...

Protalix BioTherapeutics, Inc. (NYSE: PLX), a biopharmaceutical company specializing in the development, production, and commercialization of recombinant therapeutic proteins, recently disclosed its ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

While gout is commonly linked to excessive drinking or poor diet, new research has revealed that genetics may play a larger ...

USA: A recent study has shed light on the potential advantages of sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients experiencing recurrent nephrolithiasis, especially those with ...

The use of SGLT2 inhibitors vs sulfonylurea was associated with a reduced risk for incident gout and MACE among patients with type 2 diabetes with/at risk for gout.

Scientists from the University of California San Diego have uncovered a new cause of gout that could lead to more effective ...